4nd
edition

Pronovea Pharma Summit 2025: Drug Safety and Risk Management

14 - 15 May 2025
Berlin | Physical | Online | Hybrid
Over 1 million adverse drug reactions are reported each year in Europe alone, highlighting the urgent need for vigilant pharmacovigilance practices. In today’s complex landscape, pharmacovigilance has become more essential than ever, with challenges like adverse reactions, unpredictable drug interactions, and gaps in cross-border regulations creating significant risks for patient safety. Join us at Pronovea’s 4th edition of Drug Safety and Risk Management Summit as we explore transformative trends, embrace real-world evidence, navigate the latest updates in pharmacovigilance and expanding its scope to address the emerging issues in pharmacovigilance today, offering new perspectives and actionable strategies that reflect the latest industry trends and challenges.
Request Agenda

Topic Highlights

  • Addressing inconsistencies in regulatory frameworks across different EU regions and improving global collaboration.
  • Exploring the role of AI/ML in predicting adverse events and improving pharmacovigilance processes.
  • Enhancing the collection of real-world data to monitor the long-term safety of medications after they reach the market.
  • Improving Signal Detection through Big Data and Advanced Analytics: Leveraging large datasets and analytics to enhance the detection and evaluation of safety signals.
  • Effective communication of drug safety risks to healthcare professionals, patients, and the public.
  • Protecting sensitive data in drug safety systems, particularly as digital tools and cloud technologies become more prevalent.
  • Addressing the Rise of Counterfeit Drugs in Global Markets: Strategies for improving drug traceability and combatting counterfeit medicines that pose significant safety risks.
  • Ecopharmacovigilance: Reducing environmental impact and enhancing patient safety by integrating eco-pharmacovigilance practices.
  • Enhancing pharmacovigilance systems across the EU to ensure real-time monitoring and reporting of adverse drug reactions (ADRs)
  • Overcoming the Challenges in Implementing and Optimizing EudraVigilance for Drug Safety in the EU

Meet the experts

Pronovea has carefully gathered an expert speaker panel of leaders, directors, scholars, and innovators to outline the Drug Safety and Risk Management challenges and opportunities. Sign up to get insights from top pharmacovigilance pioneers, healthcare innovators, and industry experts, and take part in various case study exhibits, optimistic panel discussions, and interactive breakout sessions tailored to your specific needs.

Karsten Lollike Photo
Novo Nordisk Logo
Karsten Lollike

Novo Nordisk

Corporate Vice President & QPPV Global Safety

Dr. Mohammed Ali Kotal Photo
Sandoz Logo
Dr. Mohammed Ali Kotal

Sandoz

Global Head Medical Safety and Site Head

Yvonne Nanciu Photo
Bayer Logo
Yvonne Nanciu

Bayer

PV Country Head Germany and Deputy EU QPPV

Maria Maddalena Lino Photo
Pfizer Logo
Maria Maddalena Lino

Pfizer

Safety risk Lead Director

Sanjeev Shrivastav Photo
BionTech Logo
Sanjeev Shrivastav

BionTech

Signal Management Lead

Dr. Balaji Malla Photo
Dr. Reddy Labs Logo
Dr. Balaji Malla

Dr. Reddy Labs

Head of Pharmacovigilance, QPPV- EU & UK

Request Agenda for Full Speakers List

takeaways and benefits

Pronovea provides an excellent opportunity to connect and reconnect. Our summits provide you with a way of building connections and forging partnerships, as a strong network is necessary for corporate success. We bring a valuable forum for a range of different functions, helping people to share ideas, make decisions, and build team relationships across industries.

what people say about us

Our relationships with our clients are the most important and valuable part of our work and what we stand for. As our clients come from Europe, USA, Middle East, Asia, and Africa, our conferences truly take place worldwide. Senior decision-makers from all over the world meet at our summits to discuss the biggest problems facing their industry and to find viable solutions.

We at pronovea provide the market's most interactive and high-quality corporate conferences. We deliver the banking, telecom, pharma, and technology industries access to the most progressive and advanced business expertise available anywhere on the globe in one place. In order to return to their organisations with new, constructive ideas on how to advance their businesses, our clients depend on us to offer this information.

Commerz Direktservice GmbH Logo
Specialist & Product Owner in Digitalization, Chat Bots & AI
Commerz Direktservice GmbH

I had a great experience at the PRONOVEA Summit in Vienna, where I held a presentation on Automation Strategies. It was inspiring to discuss with colleagues all over the world, that face the same challenges and go the extra mile in creating sustainable digitalization strategies.

Novartis Logo
Head of Novartis
Novartis

I had the pleasure of speaking at the 2022 PRONOVEA Pharma Summit in beautiful Vienna and meeting amazing people. I am looking forward to next time.

SAP Logo
Global Customer Experience Advisor
SAP

I feel energized after having met and connected with several business leaders worldwide Pronovea Summit in Vienna! Thanks for allowing me to be part of this great event!

TSB Bank Logo
Strategic Customer Insights Manager
TSB Bank

It was great to be a part of the Pronovea Summit. I heard some inspiring shares, and the passion for delivering customer-centric solutions via channels B2B and B2C is amazing. Looking forward to a positive future. Great job PRONOVEA.

Etisalat Logo
Customer Service & Digital Channel Management
Etisalat

Thank you, Pronovea and all the speakers at the event - I found every bit valuable!